Login
← Go Back
Kilitch Drugs India
KILITCH · Pharma > Pharmaceuticals & Drugs · MD: Mukund P Mehta · Listing date: Sept. 29, 2010 · Employees: 123 · Mumbai · http://www.kilitch.com
Stock Price vs Company Growth
1d
2.3%
1w
0.4%
1m
4.5%
3m
11.7%
6m
0.3%
1y
10.4%
5y
21.2%
10y
23.0%
all
11.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 325 2.3%
298
388
Company Overview
Sales
158 Cr
Growth: 3.1%
Profit after Tax
16.5 Cr
Growth: 30.8%
Small Cap
523 Cr
P/E: 31.6x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 158
Growth 3.1%
EBITDA 10.9%
P/S 3.3x
Dividend 0.0%
P/E 31.6x
Book Value ₹ 116
PEG Ratio 10.1x
ROE 9.4%
P/B 2.8x
Shareholding Pattern
Institutions
Dipak Kanayalal Shah
2.65 %
Iepf
1.5 %
Llp
0.05 %
Promoters
Kilitch Company (Pharma) Limited
42.6 %
Bhavin Mukund Mehta
12.87 %
Neeta Mukund Mehta
7.14 %
Mukund Mehta
5.72 %
Others
Increase    Decrease    No change
Company Profile Detailed
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India.
Investors (27)
dipak.ka...
dipak.sh...
bp.fintr...
Followers (1)
paras5